Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials

Lizhen Zhu; Caixia Dong; Ying Cao; Xuefeng Fang; Chenhan Zhong; Dan Li; Ying Yuan

doi:10.1371/journal.pone.0154795

Loading metrics

Open Access

Peer-reviewed

Research Article

Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials

Lizhen Zhu ,

Contributed equally to this work with: Lizhen Zhu, Caixia Dong

¶‡ These authors are co-first authors on this work.

Affiliation Department of Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China
⨯
Caixia Dong ,

Contributed equally to this work with: Lizhen Zhu, Caixia Dong

¶‡ These authors are co-first authors on this work.

Affiliation Department of Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China
⨯
Ying Cao,

Affiliation Department of Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China
⨯
Xuefeng Fang,

Affiliation Department of Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China
⨯
Chenhan Zhong,

Affiliation Department of Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China
⨯
Dan Li,

Affiliation Department of Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China
⨯
Ying Yuan

* E-mail: yuanying1999@zju.edu.cn

Affiliations Department of Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China, Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, Chinese National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China
⨯

Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials

Lizhen Zhu,
Caixia Dong,
Ying Cao,
Xuefeng Fang,
Chenhan Zhong,
Dan Li,
Ying Yuan

Published: May 3, 2016
https://doi.org/10.1371/journal.pone.0154795

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Adjuvant chemotherapy
Is the Subject Area "Adjuvant chemotherapy" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Curative resection
Is the Subject Area "Curative resection" applicable to this article?

Thanks for your feedback.
Patients
Is the Subject Area "Patients" applicable to this article?

Thanks for your feedback.
Polymerase chain reaction
Is the Subject Area "Polymerase chain reaction" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.